Authors
Loading...
Preclinical study demonstrates simvastatin pretreatment reduces cardiac damage and dysfunction after chronic reperfusion in mice, suggesting durable cardioprotective benefits.
Jones et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: